Animal blood is one of the main by-products of animal slaughtering and processing. It has rich protein content and high nutritional value. Plasma protein, as an important protein material, can be used for animal feed and food processing. Studies have shown that plasma proteins are enzymatically treated to obtain hydrolysates consisting of small peptides and amino acids, which are more easily digested and absorbed by the body. At the same time, they show antioxidant properties, inhibition of angiotensin converting enzyme activity, attenuation, and other functional properties and can be used as potential nutrients. Supplements, food additives, and nutraceuticals.
Plasma protein is the most important solid component in plasma, and its amino acid content is rich and its nutritional value is high. At present, it is mainly processed into plasma protein powder as livestock feed or nutritional supplement, or as a raw material or additive for various food systems [11]. Studies have shown that plasma proteins are hydrolyzed by specific enzymes to produce hydrolysates consisting of small peptides and amino acids, which are more easily digested and absorbed by the human body. At the same time, they show antioxidation, inhibition of angiotensin-converting enzyme (ACE) and attenuation. The functional properties of peptides isolated from them have been widely studied as potential nutritional supplements, food additives and nutraceuticals.
Market Analysis and Insights: Global Animal Blood Plasma Products and Derivatives Market
The global Animal Blood Plasma Products and Derivatives market size is projected to reach US$ 1541.4 million by 2027, from US$ 1218.2 million in 2020, at a CAGR of 4.0% during 2021-2027.
Global Animal Blood Plasma Products and Derivatives Scope and Segment
The global Animal Blood Plasma Products and Derivatives market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Animal Blood Plasma Products and Derivatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Immunoglobulin
Fibrinogen
Serum Albumin
Fetal Bovine Serum
By the end users/application, this report covers the following segments
Cell Culture Media
Food Industry
Pharmaceutical Industry
Sports Nutrition
Nutrition Supplements
Cosmetic Industry
Diagnostic Industry
Pet Food Industry
Competitive Landscape:
The report provides a list of all the key players in the Animal Blood Plasma Products and Derivatives market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Animal Blood Plasma Products and Derivatives key manufacturers in this market include:
Lake Immunogenics
Auckland BioSciences
Kraeber & Co. GmbH
Sigma-Aldrich
Thermo Fisher Scientific
Rocky Mountain Biologicals
LAMPIRE Biological Laboratories
Bovogen Biologicals
Proliant
ANZCO Foods
Plasma protein is the most important solid component in plasma, and its amino acid content is rich and its nutritional value is high. At present, it is mainly processed into plasma protein powder as livestock feed or nutritional supplement, or as a raw material or additive for various food systems [11]. Studies have shown that plasma proteins are hydrolyzed by specific enzymes to produce hydrolysates consisting of small peptides and amino acids, which are more easily digested and absorbed by the human body. At the same time, they show antioxidation, inhibition of angiotensin-converting enzyme (ACE) and attenuation. The functional properties of peptides isolated from them have been widely studied as potential nutritional supplements, food additives and nutraceuticals.
Market Analysis and Insights: Global Animal Blood Plasma Products and Derivatives Market
The global Animal Blood Plasma Products and Derivatives market size is projected to reach US$ 1541.4 million by 2027, from US$ 1218.2 million in 2020, at a CAGR of 4.0% during 2021-2027.
Global Animal Blood Plasma Products and Derivatives Scope and Segment
The global Animal Blood Plasma Products and Derivatives market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Animal Blood Plasma Products and Derivatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Immunoglobulin
Fibrinogen
Serum Albumin
Fetal Bovine Serum
By the end users/application, this report covers the following segments
Cell Culture Media
Food Industry
Pharmaceutical Industry
Sports Nutrition
Nutrition Supplements
Cosmetic Industry
Diagnostic Industry
Pet Food Industry
Competitive Landscape:
The report provides a list of all the key players in the Animal Blood Plasma Products and Derivatives market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Animal Blood Plasma Products and Derivatives key manufacturers in this market include:
Lake Immunogenics
Auckland BioSciences
Kraeber & Co. GmbH
Sigma-Aldrich
Thermo Fisher Scientific
Rocky Mountain Biologicals
LAMPIRE Biological Laboratories
Bovogen Biologicals
Proliant
ANZCO Foods
1 Animal Blood Plasma Products and Derivatives Market Overview
1.1 Animal Blood Plasma Products and Derivatives Product Overview
1.2 Animal Blood Plasma Products and Derivatives Market Segment by Type
1.2.1 Immunoglobulin
1.2.2 Fibrinogen
1.2.3 Serum Albumin
1.2.4 Fetal Bovine Serum
1.3 Global Animal Blood Plasma Products and Derivatives Market Size by Type
1.3.1 Global Animal Blood Plasma Products and Derivatives Market Size Overview by Type (2016-2027)
1.3.2 Global Animal Blood Plasma Products and Derivatives Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Animal Blood Plasma Products and Derivatives Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Animal Blood Plasma Products and Derivatives Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Animal Blood Plasma Products and Derivatives Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Animal Blood Plasma Products and Derivatives Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Animal Blood Plasma Products and Derivatives Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Animal Blood Plasma Products and Derivatives Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Animal Blood Plasma Products and Derivatives Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Animal Blood Plasma Products and Derivatives Sales Breakdown by Type (2016-2021)
1.4.2 Europe Animal Blood Plasma Products and Derivatives Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Animal Blood Plasma Products and Derivatives Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales Breakdown by Type (2016-2021)
2 Global Animal Blood Plasma Products and Derivatives Market Competition by Company
2.1 Global Top Players by Animal Blood Plasma Products and Derivatives Sales (2016-2021)
2.2 Global Top Players by Animal Blood Plasma Products and Derivatives Revenue (2016-2021)
2.3 Global Top Players Animal Blood Plasma Products and Derivatives Price (2016-2021)
2.4 Global Top Manufacturers Animal Blood Plasma Products and Derivatives Manufacturing Base Distribution, Sales Area, Product Type
2.5 Animal Blood Plasma Products and Derivatives Market Competitive Situation and Trends
2.5.1 Animal Blood Plasma Products and Derivatives Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Animal Blood Plasma Products and Derivatives Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Animal Blood Plasma Products and Derivatives as of 2020)
2.7 Date of Key Manufacturers Enter into Animal Blood Plasma Products and Derivatives Market
2.8 Key Manufacturers Animal Blood Plasma Products and Derivatives Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Animal Blood Plasma Products and Derivatives Status and Outlook by Region
3.1 Global Animal Blood Plasma Products and Derivatives Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Animal Blood Plasma Products and Derivatives Historic Market Size by Region
3.2.1 Global Animal Blood Plasma Products and Derivatives Sales in Volume by Region (2016-2021)
3.2.2 Global Animal Blood Plasma Products and Derivatives Sales in Value by Region (2016-2021)
3.2.3 Global Animal Blood Plasma Products and Derivatives Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Animal Blood Plasma Products and Derivatives Forecasted Market Size by Region
3.3.1 Global Animal Blood Plasma Products and Derivatives Sales in Volume by Region (2022-2027)
3.3.2 Global Animal Blood Plasma Products and Derivatives Sales in Value by Region (2022-2027)
3.3.3 Global Animal Blood Plasma Products and Derivatives Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Animal Blood Plasma Products and Derivatives by Application
4.1 Animal Blood Plasma Products and Derivatives Market Segment by Application
4.1.1 Cell Culture Media
4.1.2 Food Industry
4.1.3 Pharmaceutical Industry
4.1.4 Sports Nutrition
4.1.5 Nutrition Supplements
4.1.6 Cosmetic Industry
4.1.7 Diagnostic Industry
4.1.8 Pet Food Industry
4.2 Global Animal Blood Plasma Products and Derivatives Market Size by Application
4.2.1 Global Animal Blood Plasma Products and Derivatives Market Size Overview by Application (2016-2027)
4.2.2 Global Animal Blood Plasma Products and Derivatives Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Animal Blood Plasma Products and Derivatives Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Animal Blood Plasma Products and Derivatives Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Animal Blood Plasma Products and Derivatives Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Animal Blood Plasma Products and Derivatives Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Animal Blood Plasma Products and Derivatives Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Animal Blood Plasma Products and Derivatives Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Animal Blood Plasma Products and Derivatives Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Animal Blood Plasma Products and Derivatives Sales Breakdown by Application (2016-2021)
4.3.2 Europe Animal Blood Plasma Products and Derivatives Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Animal Blood Plasma Products and Derivatives Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales Breakdown by Application (2016-2021)
5 North America Animal Blood Plasma Products and Derivatives by Country
5.1 North America Animal Blood Plasma Products and Derivatives Historic Market Size by Country
5.1.1 North America Animal Blood Plasma Products and Derivatives Sales in Volume by Country (2016-2021)
5.1.2 North America Animal Blood Plasma Products and Derivatives Sales in Value by Country (2016-2021)
5.2 North America Animal Blood Plasma Products and Derivatives Forecasted Market Size by Country
5.2.1 North America Animal Blood Plasma Products and Derivatives Sales in Volume by Country (2022-2027)
5.2.2 North America Animal Blood Plasma Products and Derivatives Sales in Value by Country (2022-2027)
6 Europe Animal Blood Plasma Products and Derivatives by Country
6.1 Europe Animal Blood Plasma Products and Derivatives Historic Market Size by Country
6.1.1 Europe Animal Blood Plasma Products and Derivatives Sales in Volume by Country (2016-2021)
6.1.2 Europe Animal Blood Plasma Products and Derivatives Sales in Value by Country (2016-2021)
6.2 Europe Animal Blood Plasma Products and Derivatives Forecasted Market Size by Country
6.2.1 Europe Animal Blood Plasma Products and Derivatives Sales in Volume by Country (2022-2027)
6.2.2 Europe Animal Blood Plasma Products and Derivatives Sales in Value by Country (2022-2027)
7 Asia-Pacific Animal Blood Plasma Products and Derivatives by Region
7.1 Asia-Pacific Animal Blood Plasma Products and Derivatives Historic Market Size by Region
7.1.1 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Animal Blood Plasma Products and Derivatives Forecasted Market Size by Region
7.2.1 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales in Value by Region (2022-2027)
8 Latin America Animal Blood Plasma Products and Derivatives by Country
8.1 Latin America Animal Blood Plasma Products and Derivatives Historic Market Size by Country
8.1.1 Latin America Animal Blood Plasma Products and Derivatives Sales in Volume by Country (2016-2021)
8.1.2 Latin America Animal Blood Plasma Products and Derivatives Sales in Value by Country (2016-2021)
8.2 Latin America Animal Blood Plasma Products and Derivatives Forecasted Market Size by Country
8.2.1 Latin America Animal Blood Plasma Products and Derivatives Sales in Volume by Country (2022-2027)
8.2.2 Latin America Animal Blood Plasma Products and Derivatives Sales in Value by Country (2022-2027)
9 Middle East and Africa Animal Blood Plasma Products and Derivatives by Country
9.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Historic Market Size by Country
9.1.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Forecasted Market Size by Country
9.2.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Animal Blood Plasma Products and Derivatives Business
10.1 Lake Immunogenics
10.1.1 Lake Immunogenics Corporation Information
10.1.2 Lake Immunogenics Introduction and Business Overview
10.1.3 Lake Immunogenics Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Lake Immunogenics Animal Blood Plasma Products and Derivatives Products Offered
10.1.5 Lake Immunogenics Recent Development
10.2 Auckland BioSciences
10.2.1 Auckland BioSciences Corporation Information
10.2.2 Auckland BioSciences Introduction and Business Overview
10.2.3 Auckland BioSciences Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Lake Immunogenics Animal Blood Plasma Products and Derivatives Products Offered
10.2.5 Auckland BioSciences Recent Development
10.3 Kraeber & Co. GmbH
10.3.1 Kraeber & Co. GmbH Corporation Information
10.3.2 Kraeber & Co. GmbH Introduction and Business Overview
10.3.3 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Products Offered
10.3.5 Kraeber & Co. GmbH Recent Development
10.4 Sigma-Aldrich
10.4.1 Sigma-Aldrich Corporation Information
10.4.2 Sigma-Aldrich Introduction and Business Overview
10.4.3 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Products Offered
10.4.5 Sigma-Aldrich Recent Development
10.5 Thermo Fisher Scientific
10.5.1 Thermo Fisher Scientific Corporation Information
10.5.2 Thermo Fisher Scientific Introduction and Business Overview
10.5.3 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Products Offered
10.5.5 Thermo Fisher Scientific Recent Development
10.6 Rocky Mountain Biologicals
10.6.1 Rocky Mountain Biologicals Corporation Information
10.6.2 Rocky Mountain Biologicals Introduction and Business Overview
10.6.3 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Products Offered
10.6.5 Rocky Mountain Biologicals Recent Development
10.7 LAMPIRE Biological Laboratories
10.7.1 LAMPIRE Biological Laboratories Corporation Information
10.7.2 LAMPIRE Biological Laboratories Introduction and Business Overview
10.7.3 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2016-2021)
10.7.4 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Products Offered
10.7.5 LAMPIRE Biological Laboratories Recent Development
10.8 Bovogen Biologicals
10.8.1 Bovogen Biologicals Corporation Information
10.8.2 Bovogen Biologicals Introduction and Business Overview
10.8.3 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Products Offered
10.8.5 Bovogen Biologicals Recent Development
10.9 Proliant
10.9.1 Proliant Corporation Information
10.9.2 Proliant Introduction and Business Overview
10.9.3 Proliant Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Proliant Animal Blood Plasma Products and Derivatives Products Offered
10.9.5 Proliant Recent Development
10.10 ANZCO Foods
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Animal Blood Plasma Products and Derivatives Product Category, Application and Specification
10.10.3 ANZCO Foods Animal Blood Plasma Products and Derivatives Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 ANZCO Foods Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Animal Blood Plasma Products and Derivatives Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Animal Blood Plasma Products and Derivatives Industrial Chain Analysis
11.4 Animal Blood Plasma Products and Derivatives Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Animal Blood Plasma Products and Derivatives Distributors
12.3 Animal Blood Plasma Products and Derivatives Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Animal Blood Plasma Products and Derivatives Product Overview
1.2 Animal Blood Plasma Products and Derivatives Market Segment by Type
1.2.1 Immunoglobulin
1.2.2 Fibrinogen
1.2.3 Serum Albumin
1.2.4 Fetal Bovine Serum
1.3 Global Animal Blood Plasma Products and Derivatives Market Size by Type
1.3.1 Global Animal Blood Plasma Products and Derivatives Market Size Overview by Type (2016-2027)
1.3.2 Global Animal Blood Plasma Products and Derivatives Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Animal Blood Plasma Products and Derivatives Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Animal Blood Plasma Products and Derivatives Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Animal Blood Plasma Products and Derivatives Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Animal Blood Plasma Products and Derivatives Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Animal Blood Plasma Products and Derivatives Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Animal Blood Plasma Products and Derivatives Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Animal Blood Plasma Products and Derivatives Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Animal Blood Plasma Products and Derivatives Sales Breakdown by Type (2016-2021)
1.4.2 Europe Animal Blood Plasma Products and Derivatives Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Animal Blood Plasma Products and Derivatives Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales Breakdown by Type (2016-2021)
2 Global Animal Blood Plasma Products and Derivatives Market Competition by Company
2.1 Global Top Players by Animal Blood Plasma Products and Derivatives Sales (2016-2021)
2.2 Global Top Players by Animal Blood Plasma Products and Derivatives Revenue (2016-2021)
2.3 Global Top Players Animal Blood Plasma Products and Derivatives Price (2016-2021)
2.4 Global Top Manufacturers Animal Blood Plasma Products and Derivatives Manufacturing Base Distribution, Sales Area, Product Type
2.5 Animal Blood Plasma Products and Derivatives Market Competitive Situation and Trends
2.5.1 Animal Blood Plasma Products and Derivatives Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Animal Blood Plasma Products and Derivatives Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Animal Blood Plasma Products and Derivatives as of 2020)
2.7 Date of Key Manufacturers Enter into Animal Blood Plasma Products and Derivatives Market
2.8 Key Manufacturers Animal Blood Plasma Products and Derivatives Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Animal Blood Plasma Products and Derivatives Status and Outlook by Region
3.1 Global Animal Blood Plasma Products and Derivatives Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Animal Blood Plasma Products and Derivatives Historic Market Size by Region
3.2.1 Global Animal Blood Plasma Products and Derivatives Sales in Volume by Region (2016-2021)
3.2.2 Global Animal Blood Plasma Products and Derivatives Sales in Value by Region (2016-2021)
3.2.3 Global Animal Blood Plasma Products and Derivatives Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Animal Blood Plasma Products and Derivatives Forecasted Market Size by Region
3.3.1 Global Animal Blood Plasma Products and Derivatives Sales in Volume by Region (2022-2027)
3.3.2 Global Animal Blood Plasma Products and Derivatives Sales in Value by Region (2022-2027)
3.3.3 Global Animal Blood Plasma Products and Derivatives Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Animal Blood Plasma Products and Derivatives by Application
4.1 Animal Blood Plasma Products and Derivatives Market Segment by Application
4.1.1 Cell Culture Media
4.1.2 Food Industry
4.1.3 Pharmaceutical Industry
4.1.4 Sports Nutrition
4.1.5 Nutrition Supplements
4.1.6 Cosmetic Industry
4.1.7 Diagnostic Industry
4.1.8 Pet Food Industry
4.2 Global Animal Blood Plasma Products and Derivatives Market Size by Application
4.2.1 Global Animal Blood Plasma Products and Derivatives Market Size Overview by Application (2016-2027)
4.2.2 Global Animal Blood Plasma Products and Derivatives Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Animal Blood Plasma Products and Derivatives Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Animal Blood Plasma Products and Derivatives Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Animal Blood Plasma Products and Derivatives Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Animal Blood Plasma Products and Derivatives Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Animal Blood Plasma Products and Derivatives Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Animal Blood Plasma Products and Derivatives Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Animal Blood Plasma Products and Derivatives Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Animal Blood Plasma Products and Derivatives Sales Breakdown by Application (2016-2021)
4.3.2 Europe Animal Blood Plasma Products and Derivatives Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Animal Blood Plasma Products and Derivatives Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales Breakdown by Application (2016-2021)
5 North America Animal Blood Plasma Products and Derivatives by Country
5.1 North America Animal Blood Plasma Products and Derivatives Historic Market Size by Country
5.1.1 North America Animal Blood Plasma Products and Derivatives Sales in Volume by Country (2016-2021)
5.1.2 North America Animal Blood Plasma Products and Derivatives Sales in Value by Country (2016-2021)
5.2 North America Animal Blood Plasma Products and Derivatives Forecasted Market Size by Country
5.2.1 North America Animal Blood Plasma Products and Derivatives Sales in Volume by Country (2022-2027)
5.2.2 North America Animal Blood Plasma Products and Derivatives Sales in Value by Country (2022-2027)
6 Europe Animal Blood Plasma Products and Derivatives by Country
6.1 Europe Animal Blood Plasma Products and Derivatives Historic Market Size by Country
6.1.1 Europe Animal Blood Plasma Products and Derivatives Sales in Volume by Country (2016-2021)
6.1.2 Europe Animal Blood Plasma Products and Derivatives Sales in Value by Country (2016-2021)
6.2 Europe Animal Blood Plasma Products and Derivatives Forecasted Market Size by Country
6.2.1 Europe Animal Blood Plasma Products and Derivatives Sales in Volume by Country (2022-2027)
6.2.2 Europe Animal Blood Plasma Products and Derivatives Sales in Value by Country (2022-2027)
7 Asia-Pacific Animal Blood Plasma Products and Derivatives by Region
7.1 Asia-Pacific Animal Blood Plasma Products and Derivatives Historic Market Size by Region
7.1.1 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Animal Blood Plasma Products and Derivatives Forecasted Market Size by Region
7.2.1 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales in Value by Region (2022-2027)
8 Latin America Animal Blood Plasma Products and Derivatives by Country
8.1 Latin America Animal Blood Plasma Products and Derivatives Historic Market Size by Country
8.1.1 Latin America Animal Blood Plasma Products and Derivatives Sales in Volume by Country (2016-2021)
8.1.2 Latin America Animal Blood Plasma Products and Derivatives Sales in Value by Country (2016-2021)
8.2 Latin America Animal Blood Plasma Products and Derivatives Forecasted Market Size by Country
8.2.1 Latin America Animal Blood Plasma Products and Derivatives Sales in Volume by Country (2022-2027)
8.2.2 Latin America Animal Blood Plasma Products and Derivatives Sales in Value by Country (2022-2027)
9 Middle East and Africa Animal Blood Plasma Products and Derivatives by Country
9.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Historic Market Size by Country
9.1.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Forecasted Market Size by Country
9.2.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Animal Blood Plasma Products and Derivatives Business
10.1 Lake Immunogenics
10.1.1 Lake Immunogenics Corporation Information
10.1.2 Lake Immunogenics Introduction and Business Overview
10.1.3 Lake Immunogenics Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Lake Immunogenics Animal Blood Plasma Products and Derivatives Products Offered
10.1.5 Lake Immunogenics Recent Development
10.2 Auckland BioSciences
10.2.1 Auckland BioSciences Corporation Information
10.2.2 Auckland BioSciences Introduction and Business Overview
10.2.3 Auckland BioSciences Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Lake Immunogenics Animal Blood Plasma Products and Derivatives Products Offered
10.2.5 Auckland BioSciences Recent Development
10.3 Kraeber & Co. GmbH
10.3.1 Kraeber & Co. GmbH Corporation Information
10.3.2 Kraeber & Co. GmbH Introduction and Business Overview
10.3.3 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Products Offered
10.3.5 Kraeber & Co. GmbH Recent Development
10.4 Sigma-Aldrich
10.4.1 Sigma-Aldrich Corporation Information
10.4.2 Sigma-Aldrich Introduction and Business Overview
10.4.3 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Products Offered
10.4.5 Sigma-Aldrich Recent Development
10.5 Thermo Fisher Scientific
10.5.1 Thermo Fisher Scientific Corporation Information
10.5.2 Thermo Fisher Scientific Introduction and Business Overview
10.5.3 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Products Offered
10.5.5 Thermo Fisher Scientific Recent Development
10.6 Rocky Mountain Biologicals
10.6.1 Rocky Mountain Biologicals Corporation Information
10.6.2 Rocky Mountain Biologicals Introduction and Business Overview
10.6.3 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Products Offered
10.6.5 Rocky Mountain Biologicals Recent Development
10.7 LAMPIRE Biological Laboratories
10.7.1 LAMPIRE Biological Laboratories Corporation Information
10.7.2 LAMPIRE Biological Laboratories Introduction and Business Overview
10.7.3 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2016-2021)
10.7.4 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Products Offered
10.7.5 LAMPIRE Biological Laboratories Recent Development
10.8 Bovogen Biologicals
10.8.1 Bovogen Biologicals Corporation Information
10.8.2 Bovogen Biologicals Introduction and Business Overview
10.8.3 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Products Offered
10.8.5 Bovogen Biologicals Recent Development
10.9 Proliant
10.9.1 Proliant Corporation Information
10.9.2 Proliant Introduction and Business Overview
10.9.3 Proliant Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Proliant Animal Blood Plasma Products and Derivatives Products Offered
10.9.5 Proliant Recent Development
10.10 ANZCO Foods
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Animal Blood Plasma Products and Derivatives Product Category, Application and Specification
10.10.3 ANZCO Foods Animal Blood Plasma Products and Derivatives Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 ANZCO Foods Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Animal Blood Plasma Products and Derivatives Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Animal Blood Plasma Products and Derivatives Industrial Chain Analysis
11.4 Animal Blood Plasma Products and Derivatives Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Animal Blood Plasma Products and Derivatives Distributors
12.3 Animal Blood Plasma Products and Derivatives Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
